PW Medtech Group Limited (HKG:1358)
Hong Kong
· Delayed Price · Currency is HKD 1.090
-0.180 (-14.17%)
Mar 10, 2026, 11:50 AM HKT
PW Medtech Group Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 1,863 | 1,487 | 1,284 | 986 | 1,569 | 3,374 | Upgrade
|
| Market Cap Growth | 34.77% | 15.81% | 30.16% | -37.15% | -53.49% | 52.48% | Upgrade
|
| Enterprise Value | 880 | 497 | 524 | 179 | -1,308 | 3,069 | Upgrade
|
| Last Close Price | 1.27 | 0.93 | 0.70 | 0.51 | 0.80 | 0.55 | Upgrade
|
| PE Ratio | 11.90 | 9.27 | 7.61 | 8.23 | 1.73 | 4.50 | Upgrade
|
| Forward PE | - | 4.64 | 4.64 | 4.64 | 4.64 | 4.64 | Upgrade
|
| PS Ratio | 2.01 | 1.82 | 1.73 | 1.63 | 4.71 | 11.49 | Upgrade
|
| PB Ratio | 0.35 | 0.29 | 0.24 | 0.19 | 0.34 | 0.56 | Upgrade
|
| P/TBV Ratio | 0.71 | 0.59 | 0.37 | 0.29 | 0.35 | 0.58 | Upgrade
|
| P/FCF Ratio | 8.38 | 5.33 | 7.12 | 4.03 | 49.32 | 40.40 | Upgrade
|
| P/OCF Ratio | 5.99 | 4.39 | 5.52 | 3.24 | 34.33 | 36.33 | Upgrade
|
| PEG Ratio | - | 0.40 | 0.40 | 0.40 | 0.40 | 0.40 | Upgrade
|
| EV/Sales Ratio | 0.95 | 0.61 | 0.71 | 0.29 | - | 10.45 | Upgrade
|
| EV/EBITDA Ratio | 2.58 | 1.61 | 1.72 | 0.90 | - | 878.30 | Upgrade
|
| EV/EBIT Ratio | 4.56 | 2.68 | 2.66 | 1.61 | - | - | Upgrade
|
| EV/FCF Ratio | 3.96 | 1.78 | 2.91 | 0.73 | - | 36.74 | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.00 | 0 | 0.00 | 0.00 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | 0.07 | 0.04 | 0.00 | 0.02 | 0.03 | 8.14 | Upgrade
|
| Debt / FCF Ratio | 0.10 | 0.05 | 0.01 | 0.02 | 0.09 | 0.43 | Upgrade
|
| Net Debt / Equity Ratio | -0.36 | -0.35 | -0.33 | -0.30 | -0.63 | -0.33 | Upgrade
|
| Net Debt / EBITDA Ratio | -5.69 | -5.79 | -5.77 | -7.88 | -30.90 | -568.09 | Upgrade
|
| Net Debt / FCF Ratio | -8.66 | -6.39 | -9.73 | -6.38 | -92.94 | -23.76 | Upgrade
|
| Asset Turnover | 0.16 | 0.15 | 0.13 | 0.12 | 0.06 | 0.05 | Upgrade
|
| Inventory Turnover | 2.91 | 2.72 | 2.19 | 2.88 | 2.92 | 2.62 | Upgrade
|
| Quick Ratio | 7.81 | 10.32 | 11.79 | 9.10 | 24.42 | 13.59 | Upgrade
|
| Current Ratio | 9.64 | 11.80 | 13.61 | 11.59 | 24.82 | 29.62 | Upgrade
|
| Return on Equity (ROE) | 3.82% | 4.00% | 4.33% | 3.06% | 16.61% | 13.00% | Upgrade
|
| Return on Assets (ROA) | 2.09% | 2.11% | 2.21% | 1.38% | 0.64% | -0.29% | Upgrade
|
| Return on Invested Capital (ROIC) | 4.77% | 4.58% | 4.90% | 3.46% | 1.95% | -0.58% | Upgrade
|
| Return on Capital Employed (ROCE) | 3.50% | 3.50% | 3.60% | 2.00% | 1.20% | -0.50% | Upgrade
|
| Earnings Yield | 8.62% | 10.79% | 13.15% | 12.15% | 57.82% | 22.24% | Upgrade
|
| FCF Yield | 11.94% | 18.75% | 14.05% | 24.84% | 2.03% | 2.48% | Upgrade
|
| Dividend Yield | 7.46% | 10.52% | 14.11% | - | - | - | Upgrade
|
| Payout Ratio | 91.68% | 89.11% | 46.74% | - | 279.01% | - | Upgrade
|
| Buyback Yield / Dilution | 3.92% | 1.42% | 0.03% | 0.20% | 0.00% | -0.00% | Upgrade
|
| Total Shareholder Return | 11.38% | 11.94% | 14.14% | 0.20% | 0.00% | -0.00% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.